Fertility Preservation Delays Breast Cancer Treatment But Doesn’t Affect Survival
An analysis of data sought to determine the effect of delays related to fertility preservation on the initiation of treatment and overall survival.
Breast Cancer
Cyclophosphamide-Free Adjuvant Chemotherapy May Preserve Fertility in Young Women With Breast Cancer
The rate of successful pregnancy was higher in young women with breast cancer who received cyclophosphamide-free adjuvant chemotherapy.
Pyrotinib Plus Capecitabine Prolongs PFS in HER2-Positive Metastatic Breast Cancer
Pyrotinib plus capecitabine bested lapatinib plus capecitabine in a phase 3 trial.
‘Harmful’ Articles on Cancer Treatment Get More Engagement on Social Media
About 31% of the articles analyzed contained information classified as harmful.
Radiotherapy Plus Trastuzumab Did Not Significantly Reduce Ipsilateral Breast Tumor Recurrence Rate in HER2+ DCIS
In the B-43 phase 3 trial, researchers did not achieve the objective of a 36% reduction in ipsilateral breast cancer rate with the addition of trastuzumab to radiotherapy.
Surgery May Improve Survival in Older Patients With Invasive Breast Cancer
Surgery was an independent predictor of overall survival.
Extended Bisphosphonate Treatment Does Not Improve Survival in High-Risk Early Breast Cancer
There was no benefit to extending zoledronate treatment beyond 2 years.
Pembrolizumab Does Not Confer Survival Benefit in Metastatic Triple-Negative Breast Cancer
Overall survival was similar with pembrolizumab and single-agent chemotherapy.
Disparities in Breast Cancer Survival Persist for Black Women
Although nearly all metrics improved for racial-ethnic minorities, recent breast cancer-related mortality in Florida still higher in Black women.
Racial Disparities in Survival Among Triple-Negative Breast Cancer Patients Partially Explained by Treatment Differences
The study showed differences in receipt of chemotherapy and surgery but not radiotherapy.
- Loading...
Loading...
Next post in Breast Cancer
Loading... 
Loading...